Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 11 de 11
Filtrar
1.
BMC Health Serv Res ; 20(1): 561, 2020 Jun 19.
Artículo en Inglés | MEDLINE | ID: mdl-32560690

RESUMEN

BACKGROUND: Nepal has made a significant improvement in child survival in the last few decades and the involvement of female community health volunteers (FCHVs) has been crucial in such achievement. While there have been many studies on child health in Nepal however, rarely explored the status and factors associated with the child health service provided by these volunteers. This study aimed to identify the factors associated with the child health service delivery by FCHVs. METHODS: A national survey was conducted in 2014 in Nepal that included 4302 FCHVs using the structured questionnaire across the 13 geopolitical domains of the country. Factors associated with the use of child health services was examined using Chi-square test (χ2) followed by logistic regression. RESULTS: Overall, 62.6% of FCHVs provided at least one child health service. Those FCHVs who utilized money from the FCHV fund, conducted health mothers' group meeting, involved in local committees and those who supported antenatal care and outreach clinics related activities had higher odds of providing child health services. Similarly, FCHVs equipped with the stock of Cotrimoxazole tablet, Zinc tablet, Oral Rehydration Salt packets were more likely to provide child health services. The province-wise analysis showed that FCHVs from Province 5 and Sudur Paschim Province were more likely to provide child health services compared to their counterparts from province 1. Technology-wise, FCHVs who were using mobile were more likely to provide child health services. CONCLUSIONS: FCHVs are important human resource in providing child health services in Nepal. To improve child health service delivery by FCHVs; availability of key commodities, involvement of FCHVs in regular health mothers' group meeting, use of mobile phone, involvement in other public health programs and social networks, and utilization of the FCHV fund need to be taken into consideration.


Asunto(s)
Servicios de Salud del Niño/organización & administración , Agentes Comunitarios de Salud/estadística & datos numéricos , Voluntarios/estadística & datos numéricos , Adulto , Niño , Femenino , Encuestas de Atención de la Salud , Humanos , Persona de Mediana Edad , Nepal
2.
PLoS One ; 13(1): e0191174, 2018.
Artículo en Inglés | MEDLINE | ID: mdl-29351313

RESUMEN

BACKGROUND: Expanding access to medication abortion through pharmacies is a promising avenue to reach women with safe and convenient care, yet no pharmacy provision interventions have been evaluated. This observational non-inferiority study investigated the effectiveness and safety of mifepristone-misoprostol medication abortion provided at pharmacies, compared to government-certified public health facilities, by trained auxiliary nurse-midwives in Nepal. METHODS: Auxiliary nurse-midwives were trained to provide medication abortion through twelve pharmacies and public facilities as part of a demonstration project in two districts. Eligible women were ≤63 days pregnant, aged 16-45, and had no medical contraindications. Between 2014-2015, participants (n = 605) obtained 200 mg mifepristone orally and 800 µg misoprostol sublingually or intravaginally 24 hours later, and followed-up 14-21 days later. The primary outcome was complete abortion without manual vacuum aspiration; the secondary outcome was complication requiring treatment. We assessed risk differences by facility type with multivariable logistic mixed-effects regression. RESULTS: Over 99% of enrolled women completed follow-up (n = 600). Complete abortions occurred in 588 (98·0%) cases, with ten incomplete abortions and two continuing pregnancies. 293/297 (98·7%) pharmacy participants and 295/303 (97·4%) public facility participants had complete abortions, with an adjusted risk difference falling within the pre-specified 5 percentage-point non-inferiority margin (1·5% [-0·8%, 3·8%]). No serious adverse events occurred. Five (1.7%) pharmacy and two (0.7%) public facility participants experienced a complication warranting treatment (aRD, 0.8% [-1.0%-2.7%]). CONCLUSIONS: Early mifepristone-misoprostol abortion was as effective and safe when provided by trained auxiliary nurse-midwives at pharmacies as at government-certified health facilities. Findings support policy expanding provision through registered pharmacies by trained auxiliary nurse-midwives to improve access to safe care.


Asunto(s)
Aborto Inducido/enfermería , Enfermeras Obstetrices , Abortivos no Esteroideos/administración & dosificación , Abortivos Esteroideos/administración & dosificación , Aborto Inducido/educación , Aborto Inducido/métodos , Adolescente , Adulto , Femenino , Accesibilidad a los Servicios de Salud , Humanos , Mifepristona/administración & dosificación , Misoprostol/administración & dosificación , Nepal , Enfermeras Obstetrices/educación , Farmacias , Embarazo , Enfermería en Salud Pública/educación , Seguridad , Resultado del Tratamiento , Adulto Joven
4.
BMC Pregnancy Childbirth ; 17(1): 169, 2017 Jun 05.
Artículo en Inglés | MEDLINE | ID: mdl-28583092

RESUMEN

BACKGROUND: In 2009, the Nepal Ministry of Health and Population launched a national program for prevention of postpartum hemorrhage (PPH) during home births that features advance distribution of misoprostol to pregnant women. In the years since, the government has scaled-up the program throughout much of the country. This paper presents findings from the first large-scale assessment of the effectiveness of the advance distribution program. METHODS: Data collection was carried out in nine districts and all three ecological zones. To assess knowledge, receipt and use of misoprostol, household interviews were conducted with 2070 women who had given birth within the past 12 months. To assess supply and provision of misoprostol, interviews were conducted with 270 Female Community Health Volunteers (FCHVs) and staff at 99 health facilities. RESULTS: Among recently delivered women, only 15% received information about misoprostol and 13% received misoprostol tablets in advance of delivery. Yet 87% who received advance misoprostol and delivered at home used it for PPH prevention. Among FCHVs, 96% were providing advance misoprostol for PPH prevention; however 81% had experienced at least one misoprostol stock out within the past year. About one-half of FCHVs were providing incomplete information about the use of misoprostol; in addition, many did not discuss side effects, how to recognize PPH or where to go if PPH occurs. Among health facilities, just one-half had sufficient misoprostol stock, while 95% had sufficient oxytocin stock, at the time of this assessment. CONCLUSIONS: In Nepal, women who receive advance misoprostol are both willing and able to use the medication for PPH prevention during home births. However the supply and personnel challenges identified raise questions about scalability and impact of the program over the long-term. Further assessment is needed.


Asunto(s)
Misoprostol/provisión & distribución , Misoprostol/uso terapéutico , Oxitócicos/provisión & distribución , Oxitócicos/uso terapéutico , Educación del Paciente como Asunto/estadística & datos numéricos , Hemorragia Posparto/prevención & control , Adolescente , Adulto , Agentes Comunitarios de Salud/estadística & datos numéricos , Femenino , Instituciones de Salud/estadística & datos numéricos , Conocimientos, Actitudes y Práctica en Salud , Humanos , Entrevistas como Asunto , Misoprostol/efectos adversos , Nepal , Oxitócicos/efectos adversos , Oxitocina/provisión & distribución , Embarazo , Evaluación de Programas y Proyectos de Salud , Voluntarios/estadística & datos numéricos , Adulto Joven
5.
JNMA J Nepal Med Assoc ; 56(208): 417-20, 2017.
Artículo en Inglés | MEDLINE | ID: mdl-29453472

RESUMEN

INTRODUCTION: Worldwide there is variation in prevalence of Hepatitis D viral infection. Superinfection and co infection with hepatitis B viral infection is known to occur in 15-20 million people. METHODS: This was a descriptive cross-sectional hospital based study carried out in NAMS, Bir hospital, Kathmandu, Nepal from period of January 2017 to June 2017. Consecutive patients of chronic hepatitis B viral infection of HBsAg positive with more than two-time upper normal limit of ALT were enrolled and tested for HDV IgG. RESULTS: Forty patients were enrolled during study period. Mean age was 30.9±12.2 years. Males were 28 (70%) and females 12 (30%). Most of the patients were asymptomatic for HBV infection 32 (80%). HBeAg negative chronic hepatitis was most commonly present in 31 (77.5%). Family history of Hepatitis B viral infection was seen in 7 (17.5%) and sexual promiscuity in 5 (12.5%) as the mode of acquisition of hepatitis B viral infection. HBcIgM was positive in three patients with mean HBV DNA of 4.97x10(5)±4.5x10(5) IU/ml in HBeAg positive group. HDV IgG was negative in all patients. CONCLUSIONS: Coinfection and superinfection of hepatitis D virus were found to be uncommon at Bir hospital, Nepal.


Asunto(s)
Coinfección/epidemiología , Hepatitis B Crónica/epidemiología , Hepatitis D/epidemiología , Adolescente , Adulto , Estudios Transversales , Femenino , Anticuerpos Antihepatitis/inmunología , Anticuerpos contra la Hepatitis B/inmunología , Antígenos del Núcleo de la Hepatitis B/inmunología , Antígenos de Superficie de la Hepatitis B/inmunología , Hepatitis B Crónica/inmunología , Hepatitis D/inmunología , Virus de la Hepatitis Delta/inmunología , Humanos , Inmunoglobulina G/inmunología , Inmunoglobulina M/inmunología , Masculino , Nepal/epidemiología , Prevalencia , Centros de Atención Terciaria , Adulto Joven
6.
JNMA J Nepal Med Assoc ; 56(208): 412-6, 2017.
Artículo en Inglés | MEDLINE | ID: mdl-29453471

RESUMEN

INTRODUCTION: Upper gastro-intestinal endoscopy remains the gold standard for screening for esophageal varices but it has its own limitations. It is an invasive, expensive and uncomfortable procedure and needs clinical expertise. Accordingly, this study was conducted to establish the role of non-invasive markers for prediction of esophageal varices in liver cirrhosis. METHODS: A hospital based descriptive cross-sectional study was carried out in Liver unit of National Academy of Medical Sciences, Bir Hospital, from October 2016 to September 2017. Complete blood count, liver function test, liver ultrasound and upper gastro-intestinal endoscopy were done for all patients to detect esophageal varices and to correlate with different non-invasive markers. RESULTS: Total 191 patients of liver cirrhosis were studied after exclusion. Platelet count of 92082.00±43435.83/mm3 and spleen size of 144.21±10.71 mm was found to be good predictors of presence of EV (P≤0.001). Significant association between Child-Turcotte-Pugh class and presence of varices was observed (P≤0.001). AST/ALT ratio with cutoff value of 1.415 showed sensitivity of 82.4% and specificity of 36.4%. APRI at a cutoff value of 1.3 showed a sensitivity of 83.2% and specificity of 50%. CONCLUSIONS: Platelet count, spleen size and Child-Turcotte-Pugh class are good predictors of presence of esophageal varices in patients with liver cirrhosis. AST/ALT ratio and APRI score are not good substitutes for upper gastro-intestinal endoscopy.


Asunto(s)
Alanina Transaminasa/sangre , Aspartato Aminotransferasas/sangre , Várices Esofágicas y Gástricas/diagnóstico , Cirrosis Hepática/sangre , Bazo/patología , Esplenomegalia/diagnóstico por imagen , Trombocitopenia/sangre , Área Bajo la Curva , Recuento de Células Sanguíneas , Estudios Transversales , Endoscopía del Sistema Digestivo , Várices Esofágicas y Gástricas/etiología , Humanos , Relación Normalizada Internacional , Hígado/diagnóstico por imagen , Cirrosis Hepática/complicaciones , Cirrosis Hepática/diagnóstico por imagen , Pruebas de Función Hepática , Nepal , Tamaño de los Órganos , Recuento de Plaquetas , Tiempo de Protrombina , Curva ROC , Sensibilidad y Especificidad , Índice de Severidad de la Enfermedad , Bazo/diagnóstico por imagen , Esplenomegalia/etiología , Trombocitopenia/etiología , Ultrasonografía
7.
BMC Pregnancy Childbirth ; 16: 241, 2016 08 24.
Artículo en Inglés | MEDLINE | ID: mdl-27553004

RESUMEN

BACKGROUND: Calcium supplementation during pregnancy has been shown to reduce the incidence of pre-eclampsia/eclampsia among women with low calcium intake. Universal free calcium supplementation through government antenatal care (ANC) services was piloted in the Dailekh district of Nepal. Coverage, compliance, acceptability and feasibility of the intervention were evaluated. METHODS: Antenatal care providers were trained to distribute and counsel pregnant women about calcium use, and female community health volunteers (FCHVs) were trained to reinforce calcium-related messages. A post-intervention cluster household survey was conducted among women who had given birth in the last six months. Secondary data analysis was performed using monitoring data from health facilities and FCHVs. RESULTS: One Thousand Two hundred-forty postpartum women were interviewed. Most (94.6 %) had attended at least one ANC visit; the median gestational age at first ANC visit was 4 months. All who attended ANC were counseled about calcium and received calcium tablets to take daily until delivery.79.5 % of the women reported consuming the entire quantity of calcium they received. The full course of calcium (300 tablets for 150 days) was provided to 82.3 % of the women. Consumption of the full course of calcium was reported by 67.3 % of all calcium recipients. Significant predictors of completing a full course were gestational age at first ANC visit and number of ANC visits during their most recent pregnancy (p < 0.01). Nearly all (99.2 %) reported taking the calcium as instructed with respect to dose, timing and frequency. Among women who received both calcium and iron (n = 1,157), 98.0 % reported taking them at different times of the day, as instructed. Over 97 % reported willingness to recommend calcium to others, and said they would like to use it during a subsequent pregnancy. There were no stock-outs of calcium. CONCLUSIONS: Calcium distribution through ANC was feasible and effective, achieving 94.6 % calcium coverage of pregnant women in the district. Most women (over 80 %) attended ANC early enough in pregnancy to receive the full course of calcium supplements and benefit from the intervention. High coverage, compliance, acceptability among pregnant women and feasibility were reported, suggesting that this intervention can be scaled up in other areas of Nepal.


Asunto(s)
Calcio de la Dieta/uso terapéutico , Suplementos Dietéticos , Eclampsia/prevención & control , Preeclampsia/prevención & control , Atención Prenatal/estadística & datos numéricos , Adulto , Eclampsia/psicología , Estudios de Factibilidad , Femenino , Humanos , Nepal , Investigación Operativa , Aceptación de la Atención de Salud/psicología , Aceptación de la Atención de Salud/estadística & datos numéricos , Cooperación del Paciente/psicología , Cooperación del Paciente/estadística & datos numéricos , Preeclampsia/psicología , Embarazo , Atención Prenatal/métodos , Atención Prenatal/psicología , Adulto Joven
8.
BMC Infect Dis ; 16(1): 450, 2016 Aug 26.
Artículo en Inglés | MEDLINE | ID: mdl-27566067

RESUMEN

BACKGROUND: Accurate and prompt diagnosis of HIV and syphilis simultaneously has reinforcing effect on their control program because of their prevalent co-infection. Availability of a simple user-friendly two-pronged and affordable detection tools brings down the cost of health care. They are important in the antenatal clinics, with added opportunity for intervention and prevention of mother to child transmission. In cooperation with rapid test kit manufacturers, SD Bioline, NPHL and NCASC, an evaluation of commercially available HIV/syphilis Duo rapid test kit (SD Bioline) to assess its performance and operational characteristics was done in the present study. METHOD: A prospective laboratory-based cross sectional study was conducted at a large Women's Hospital. Ten thousand pregnant women, visiting the Hospital for antenatal care or for delivery, were enrolled in study. Tests were performed by the SD Bioline HIV/Syphilis Duo kit as well as national algorithm for HIV and syphilis diagnosis which were considered gold standard. Sensitivity, Specificity, positive predictive value and negative predictive value along with kappa coefficient were calculated for the kit under evaluation. RESULT: The sensitivity, specificity, Negative predictive value and Positive predictive value of the kit for HIV diagnosis were 100 % (95 % CI 83.18-100 %, 99.96-100 %, 83.18-100 %, and 99.96-100 %, respectively). Kappa value was found to be 1.0. Out of total cases, results of 9985 (99.85 %) cases were concordant with National algorithm for syphilis diagnosis. Thirteen (0.13 %) cases were found false positive while two were false negative. The sensitivity of the kit for syphilis diagnosis was found to be 95.45 % (95 % CI 84.86-98.74 %) and specificity was 99.87 % (95 % CI; 99.78-99.92 %). Positive predictive value was 76.36 % (95 % CI; 63.65-85.63 %) and Negative predictive value was 99.89 % (95 % CI; 99.39-99.99 %). Kappa value was found to be 0.85. CONCLUSION: The performance characteristics of SD Bioline HIV/Syphilis duo kit were found almost concordant with the kits being used for HIV and Syphilis diagnosis separately. Its implementation in antenatal clinics/VCTs could be an added opportunity for simultaneous diagnosis of HIV and syphilis.


Asunto(s)
Coinfección/diagnóstico , Infecciones por VIH/diagnóstico , Complicaciones Infecciosas del Embarazo/diagnóstico , Juego de Reactivos para Diagnóstico , Sífilis/diagnóstico , Estudios Transversales , Femenino , Humanos , Nepal , Embarazo , Estudios Prospectivos , Sensibilidad y Especificidad
9.
Int Health ; 8(4): 261-8, 2016 07.
Artículo en Inglés | MEDLINE | ID: mdl-27048288

RESUMEN

BACKGROUND: In April 2014 we investigated the association of migration of a woman's husband with her high-risk human papillomavirus (HR-HPV) infection status and her abnormal cervical cytology status in the Achham district of rural Far-Western Nepal. METHODS: Women were surveyed and screened for HR-HPV during a health camp conducted by the Nepal Fertility Care Center. Univariate and multivariable statistical tests were performed to determine the association of a husband's migration status with HR-HPV infection and cervical cytology status. RESULTS: In 265 women, the prevalence of HR-HPV was 7.5% (20/265), while the prevalence of abnormal cervical cytology, defined using the Bethesda system as atypical glandular cells of undetermined significance or worse, was 7.6% (19/251). Half of the study participants (50.8%, 130/256) had husbands who had reported migrating for work at least once. Women aged ≤34 years were significantly less likely to test positive for HR-HPV than women aged >34 years (OR 0.22, 95% CI 0.07 to 0.71). HR-HPV infection and abnormal cervical cytology status were not directly associated with a husband's migration. CONCLUSION: Older women were found to have a higher prevalence of HPV than younger women. It is possible that a husband's migration for work could be delaying HR-HPV infections in married women until an older age.


Asunto(s)
Migración Humana , Enfermedades de Inicio Tardío/epidemiología , Infecciones por Papillomavirus/epidemiología , Población Rural/estadística & datos numéricos , Esposos , Neoplasias del Cuello Uterino/epidemiología , Adulto , Anciano , Femenino , Humanos , Masculino , Persona de Mediana Edad , Nepal/epidemiología , Prevalencia , Medición de Riesgo , Encuestas y Cuestionarios
10.
PLoS One ; 8(5): e64775, 2013.
Artículo en Inglés | MEDLINE | ID: mdl-23741391

RESUMEN

BACKGROUND: Abortion was legalized in Nepal in 2002, following advocacy efforts highlighting high maternal mortality from unsafe abortion. We sought to assess whether legalization led to reductions in the most serious maternal health consequences of unsafe abortion. METHODS: We conducted retrospective medical chart review of all gynecological cases presenting at four large public referral hospitals in Nepal. For the years 2001-2010, all cases of spontaneous and induced abortion complications were identified, abstracted, and coded to classify cases of serious infection, injury, and systemic complications. We used segmented Poisson and ordinary logistic regression to test for trend and risks of serious complications for three time periods: before implementation (2001-2003), early implementation (2004-2006), and later implementation (2007-2010). RESULTS: 23,493 cases of abortion complications were identified. A significant downward trend in the proportion of serious infection, injury, and systemic complications was observed for the later implementation period, along with a decline in the risk of serious complications (OR 0.7, 95% CI 0.64, 0.85). Reductions in sepsis occurred sooner, during early implementation (OR 0.6, 95% CI 0.47, 0.75). CONCLUSION: Over the study period, health care use and the population of reproductive aged women increased. Total fertility also declined by nearly half, despite relatively low contraceptive prevalence. Greater numbers of women likely obtained abortions and sought hospital care for complications following legalization, yet we observed a significant decline in the rate of serious abortion morbidity. The liberalization of abortion policy in Nepal has benefited women's health, and likely contributes to falling maternal mortality in the country. The steepest decline was observed after expansion of the safe abortion program to include midlevel providers, second trimester training, and medication abortion, highlighting the importance of concerted efforts to improve access. Other countries contemplating changes to abortion policy can draw on the evidence and implementation strategies observed in Nepal.


Asunto(s)
Aborto Legal/estadística & datos numéricos , Aborto Legal/efectos adversos , Aborto Legal/historia , Adulto , Femenino , Historia del Siglo XXI , Humanos , Morbilidad , Mortalidad , Nepal/epidemiología , Oportunidad Relativa , Embarazo , Estudios Retrospectivos , Factores de Riesgo , Adulto Joven
11.
Int J Gynaecol Obstet ; 108(1): 44-7, 2010 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-19744657

RESUMEN

OBJECTIVE: To evaluate patient satisfaction with the new second-trimester abortion services in Nepal. METHOD: Depending on the patient's literacy level, a questionnaire was read and filled out by the patient herself or by an interviewer. Indicators were developed and assessed to determine the patient's experience of the services, focusing on her physical, emotional, and social comfort. RESULTS: Satisfaction was found to be high for characteristics associated with counseling and the caring attitude of the physician. However, dissatisfaction was expressed regarding some aspects of the delivery of care, especially the lack of privacy and confidentiality and the absence of a support person from the patient's own family. CONCLUSION: The patients described privacy, confidentiality, and a support person designated by them as factors that would greatly contribute to their satisfaction with the services. Maximizing patient satisfaction is necessary for the program's success but will be challenging.


Asunto(s)
Aborto Inducido/normas , Satisfacción del Paciente , Calidad de la Atención de Salud , Aborto Inducido/métodos , Adolescente , Adulto , Confidencialidad/normas , Consejo/normas , Femenino , Humanos , Nepal , Relaciones Médico-Paciente , Embarazo , Segundo Trimestre del Embarazo , Privacidad , Apoyo Social , Encuestas y Cuestionarios , Adulto Joven
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...